United States News All stories

Fifth Third Bancorp (NYSE:FITB) reported third-quarter net income available to common shareholders of $828 million, with adjusted earnings reaching $1.13 per diluted share.

Biodesix (NASDAQ:BDSX) announced plans to develop an AI-powered lung nodule risk test with Vanderbilt University and Vanderbilt Health, targeting commercial availability in 2028.

BeOne Medicines (NASDAQ:ONC) announced presentations covering four investigational cancer therapies and seven TEVIMBRA abstracts at ESMO 2026 in Madrid.

Transocean (NYSE:RIG) announced two U.S. Gulf drilling contracts worth approximately $550 million in combined firm backlog for Deepwater Proteus and Deepwater Conqueror.

Perfect Corp (NYSE:PERF) received shareholder approval for its proposed $2-per-share merger with ProjectNY, securing approximately 99.99% of votes cast at its extraordinary general meeting.

Cleveland-Cliffs (NYSE:CLF) reported $612 million in third-quarter adjusted EBITDA, exceeding its $575 million guidance, as revenue reached $5.6 billion.

IDEAYA Biosciences (NASDAQ:IDYA) reported a 57% eye preservation rate in its OptimUM-09 trial, alongside updated darovasertib findings from two metastatic uveal melanoma studies.

Takeda (NYSE:TAK) reported a 67% lower relative risk of ulcerative colitis complications with ENTYVIO-based treatment targeting disease clearance rather than symptomatic remission alone.

Eli Lilly (NYSE:LLY) reported that Omvoh met its Phase 3 SHINE-2 primary endpoint, with 50% of 52 pediatric responders achieving clinical remission at Week 52.

Brent crude fell US$2.29, or 2.08%, to US$107.57 per barrel on Monday after Washington waived key Russia sanctions.

AbbVie (NYSE:ABBV) reported a 40.5% endoscopic remission rate at Week 24 for investigational ABBV-466 in its 300-patient Phase 2a TARGET-CD Crohn's disease trial.

OpenWorld (NASDAQ:OPNW) signed a definitive agreement to acquire Blocksight, supporting two proposed tokenized financing programs worth up to US$1.13 billion combined.

Red Cat Holdings (NASDAQ:RCAT) proposed acquiring Steyr Motors for €39 per share in cash, representing a 28.9% premium to the Austrian manufacturer's October 16 closing price.

BW LPG (NYSE:BWLP) reported approximately US$164 million in third-quarter gross trading results from its Product Services segment, with estimated net profit reaching US$118 million.

Telix Pharmaceuticals (NASDAQ:TLX) announced a collaboration with Ekalia to develop U.S. production of astatine-211, starting with one cyclotron installation near Philadelphia.

Oculis (NASDAQ:OCS) completed randomization of 176 patients in its PREDICT-1 registrational trial of Licaminlimab, advancing its development program for dry eye disease.

Elbit Systems (NASDAQ:ESLT) secured an approximately US$235 million contract to supply rocket artillery systems, including EXTRA-MR rockets and PULS launchers, to a European customer.

Evaxion (NASDAQ:EVAX) reported sustained clinical responses after three years in its phase 2 melanoma vaccine trial, with no tumor progression among six patients followed.

Werner Enterprises (NASDAQ:WERN) expects third-quarter 2026 revenue of $946 million to $951 million, with preliminary GAAP diluted earnings of $0.10 to $0.11 per share.

Tiziana Life Sciences (NASDAQ:TLSA) announced on October 16, 2026, that the final patient began dosing in its Phase 2 intranasal foralumab trial for early or mild Alzheimer’s disease.

Ladder Capital (NYSE:LADR) reported third-quarter 2026 GAAP income before taxes of $67.3 million and diluted earnings of $0.53 per share, supported by investment activity and an asset sale.

CLPS (NASDAQ:CLPS) reported fiscal 2026 revenue of $172.2 million, up 4.7%, despite a widening second-half net loss of $13.2 million.

Biomerica (NASDAQ:BMRA) reported a fiscal first-quarter 2027 net loss of $1.232 million, or $0.37 per share, as revenue declined 8% to $1.265 million.

NeOnc Technologies Holdings (NASDAQ:NTHI) reported early clinical improvements in one three-year-old brain tumor patient receiving investigational intranasal NEO100 through its Compassionate Care program in Abu Dhabi.